Abstract
Active antiretroviral therapy has reduced the mortality of patients with acquired immune deficiency syndrome (AIDS) and increased both the quality of life and the longevity of patients infected with human immunodeficiency virus (HIV). The long-term effects of HIV infection are increasingly observed, particularly changes in fat distribution or “lipodystrophy.” Strategies to prevent, mitigate, or reverse HIV-associated lipodystrophy have been difficult to develop. The medical management of fat redistribution usually is ineffective, and surgical approaches to HIV-associated lipodystrophy have already been described, but major drawbacks include recurrence of the fat accumulation. This report aims to describe the clinical outcomes for a man with buffalo hump who underwent lipolaser-assisted liposuction. This technique obtained a significant reduction in the size of the adiposity and an improvement in the neck’s range of motion. At this writing, after 3 years, the patient is satisfied with his cosmetic and functional results. The authors believe that lipolaser-assisted liposuction using the Smartlipo Deka-Mela neodymium:yttrium-aluminum-garnet (Nd:YAG) 1,064-mm-long pulse is effective in reducing the cervicodorsal fat pad. The technique is performed using local anesthesia with low operative risks and minimal surgical trauma. The treated zone shows rapid healing, and the whole procedure requires a day-hospital recovery, thus reducing the costs.
References
Garcia-Viejo MA, Ruiz M, Martinez E (2001) Strategies for treating HIV-related lipodystrophy. Expert Opin Investig Drugs 10:1443–1456
Powderly WG (2002) Long-term exposure to lifelong therapies. J Acquir Immune Defic Syndr 29(Suppl 1):S28–S40
Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG (2003) An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 361:726–735
Sattler F (2003) Body habitus changes related to lipodystrophy. Clin Infect Dis 36(Suppl 2):S84–S90
Lichtenstein K, Balasubramanyam A, Sekhar R, Freedland E (2007) HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanisms. AIDS Res Ther 4:14
Gold DR, Annino DJ Jr (2005) HIV-associated cervicodorsal lipodystrophy: etiology and management. Laryngoscope 115:791–795
Lichtenstein KA (2005) Redefining lipodystrophy syndrome: risks and impact on clinical decision making. J Acquir Immune Defic Syndr 39:395–400
Wohl DA, McComsey G, Tebas P (2006) Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clin Infect Dis 43:645–655
Moyle GJ (2005) Plastic surgical approaches for HIV-associated lipoatrophy. Curr HIV/AIDS Rep 2:127–131
Abood A, Ong J, Withey S (2006) Facial atrophy in HIV-related fat redistribution syndrome: a plastic surgical perspective on treatment options and a look to the future. Int J STD AIDS 17:217–220
Hultman CS, McPhail LE, Donaldson JH, Wohl DA (2007) Surgical management of HIV-associated lipodystrophy role of ultrasonic-assisted liposuction and suction-assisted lipectomy in the treatment of lipohypertrophy. Ann Plast Surg 58:255–263
Connolly N, Manders E, Riddler S (2004) Suction-assisted lipectomy for lipodystrophy. AIDS Res Hum Retroviruses 20:813–815
Goldman A (2006) Submental Nd:YAG laser-assisted liposuction. Lasers Surg Med 38:181–184
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Onesti, M.G., Fioramonti, P., Carella, S. et al. Nd:YAG Laser-Assisted Liposuction for an HIV patient. Aesth Plast Surg 34, 528–530 (2010). https://doi.org/10.1007/s00266-009-9467-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-009-9467-0